[go: up one dir, main page]

ES2055407T3 - Analogos de acidos grasos oxi- o tio-sustituidos para ser utilizados en el tratamiento de infecciones retrovirales. - Google Patents

Analogos de acidos grasos oxi- o tio-sustituidos para ser utilizados en el tratamiento de infecciones retrovirales.

Info

Publication number
ES2055407T3
ES2055407T3 ES90870135T ES90870135T ES2055407T3 ES 2055407 T3 ES2055407 T3 ES 2055407T3 ES 90870135 T ES90870135 T ES 90870135T ES 90870135 T ES90870135 T ES 90870135T ES 2055407 T3 ES2055407 T3 ES 2055407T3
Authority
ES
Spain
Prior art keywords
treatment
thio
oxy
retroviral infections
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90870135T
Other languages
English (en)
Inventor
Jeffrey Ivan Gordon
Steven Paul Adams
Robert Otto Heuckeroth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Application granted granted Critical
Publication of ES2055407T3 publication Critical patent/ES2055407T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/60—Unsaturated compounds containing ether groups, groups, groups, or groups the non-carboxylic part of the ether being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SUSTRATOS ANALOGOS DE ACIDO GRASO OXIDE ENZIMAS, CUYOS ANALOGOS CONTIENEN UN ATOMO DE OXIGENO, O DE AZUFRE, EN EL LUGAR DEL GRUPO METILENO, EN UNA POSICION DEL CARBONO ENTRE LA 4 Y LA 13 DE LA CADENA DE ACIDO GRASO, DE UN ACIDO GRASO DE C13-C14 O DE ALQUILO ESTERES DE EL, SE EMPLEAN PARA EL TRATAMIENTO DE INFECCIONES DE RETROVIRUS Y EN LA FABRICACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE INFECCIONES DE RETROVIRUS.
ES90870135T 1989-09-01 1990-08-31 Analogos de acidos grasos oxi- o tio-sustituidos para ser utilizados en el tratamiento de infecciones retrovirales. Expired - Lifetime ES2055407T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/402,094 US5073571A (en) 1988-06-16 1989-09-01 Method of inhibiting virus

Publications (1)

Publication Number Publication Date
ES2055407T3 true ES2055407T3 (es) 1994-08-16

Family

ID=23590495

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90870135T Expired - Lifetime ES2055407T3 (es) 1989-09-01 1990-08-31 Analogos de acidos grasos oxi- o tio-sustituidos para ser utilizados en el tratamiento de infecciones retrovirales.

Country Status (8)

Country Link
US (1) US5073571A (es)
EP (1) EP0415902B1 (es)
JP (1) JPH0714875B2 (es)
AT (1) ATE86854T1 (es)
CA (1) CA2024489A1 (es)
DE (1) DE69001107T2 (es)
DK (1) DK0415902T3 (es)
ES (1) ES2055407T3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69121435T2 (de) * 1990-02-26 1997-02-27 Univ Washington Verfahren zur Protein-N-Myristoylation
US5236955A (en) * 1992-04-10 1993-08-17 Washington University Anti-fungal agent
US6602861B1 (en) * 1992-04-16 2003-08-05 Research Corporation Technologies, Inc. Acylated phospholipid drugs
US5463152A (en) * 1994-12-08 1995-10-31 E. I. Du Pont De Nemours And Company Halofluorocarbon hydrogenolysis
GB2267642B (en) * 1992-06-10 1996-04-24 British Tech Group Anti-viral agents
GB9212276D0 (en) * 1992-06-10 1992-07-22 Harper David R Anti-viral agents
US5859052A (en) * 1993-01-14 1999-01-12 G. D. Searle & Co. Fatty acid analogs and prodrugs
US5599947A (en) * 1993-01-14 1997-02-04 G. D. Searle & Co. Fatty acid analogs and prodrugs
DE10063111A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Replikationsassay zur Auffindung antiviraler Substanzen
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
US9144575B2 (en) 2010-07-28 2015-09-29 Life Technologies Corporation Anti-viral azide containing compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262514A1 (en) * 1974-03-01 1975-09-26 Alary Josette Reticulo-endothelial stimulating compsn. - contg. sodium oleate, sodium stearate and neutralised olive oil
US4513005A (en) * 1981-06-18 1985-04-23 Lilly Industries Limited SRS-A antagonists
US4740588A (en) * 1986-08-07 1988-04-26 Washington University Novel substrate peptides
US4709012A (en) * 1986-08-07 1987-11-24 Washington University Novel inhibitor peptides

Also Published As

Publication number Publication date
US5073571A (en) 1991-12-17
ATE86854T1 (de) 1993-04-15
EP0415902B1 (en) 1993-03-17
JPH03109322A (ja) 1991-05-09
DK0415902T3 (da) 1993-04-19
CA2024489A1 (en) 1991-03-02
JPH0714875B2 (ja) 1995-02-22
DE69001107T2 (de) 1993-10-07
EP0415902A1 (en) 1991-03-06
DE69001107D1 (de) 1993-04-22

Similar Documents

Publication Publication Date Title
DK193488D0 (da) Saccharosefedtsyreester
AU2867089A (en) (cycloalkylamino)methylenebis(phosphonic acid) and medicines containing the same as an active ingredient
DE3868886D1 (de) Fettsaeure-zusammensetzungen.
HUT47553A (en) Process for producing azitromycin and analogues and pharmaceutical compositions containing them as active components
IT1223290B (it) Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
ES2055407T3 (es) Analogos de acidos grasos oxi- o tio-sustituidos para ser utilizados en el tratamiento de infecciones retrovirales.
EP0327847A3 (en) Organopolysiloxane compositions curable into elastomers with elimination of alcohols
DE2964709D1 (en) (dl)-16-phenoxy- and 16-substituted phenoxy-9-keto prostatrienoic acids and derivatives and processes for the production thereof and their pharmaceutical compositions
ES2061650T3 (es) Composiciones para el tratamiento de la enfermedad periodontal.
PT88994A (pt) Processo para a preparacao de 2',3'-didesoxi-2'-fluoro-nucleosidos e de composicoes farmaceuticas que os contem
ES2045120T3 (es) Metodo para preparar un medicamento para el tratamiento o la prevencion de la perdida de memoria.
EP0642525A1 (en) Chemical compounds.
ES474408A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas con agrupaciones ester sulfurosas
GB8812653D0 (en) Pharmaceutical composition based on high concentration esters of docosahexaenoic acid
ATE74346T1 (de) Alkensaeurederivate.
DK0441765T3 (da) Nye enzymsubstrater på basis af fedtsyreanaloger
DE69108616D1 (de) 3.3'-Dithiobis (Propionsäuren) und Estern davon.
ES2062282T3 (es) Proceso de racemizacion de esteres del acido carboxilico opticamente activos.
EP0357186A3 (en) Skin and hair-care compositions
ATE43348T1 (de) Acylierte cytidin-diphosphat-choline, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
DE3680832D1 (de) Herstellung von kristallinen estern von hydrophenylpropionsaeure.
BR8801724A (pt) Artigo formado de uma composicao de pvc e processo para sua preparacao
ATE85893T1 (de) Verwendung von somatostatin zur herstellung eines arzneimittels fuer die behandlung von rheumatoider arthritis.
IT1247508B (it) Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa
DE3879233D1 (de) Herstellung von carbonsaeuren und deren estern.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 415902

Country of ref document: ES